The 40 references in paper K. Korzhenevskaya V., N. Gavrischeva A., A. Panov V., T. Ses’ P., M. Alugishvili Z., V. Kozlov V., К. Корженевская В., Н. Гавришева А., А. Панов В., Т. Сесь П., М. Алугишвили З., В. Козлов В. (2014) “ТРАНСФОРМИРУЮЩИЙ ФАКТОР РОСТА-β1 ПРИ РАЗЛИЧНОМ КЛИНИЧЕСКОМ ТЕЧЕНИИ ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА ПОСЛЕ ОПЕРАЦИИ КОРОНАРНОГО ШУНТИРОВАНИЯ // TRANSFORMING GROWTH FACTOR-BETA-1 BY DIFFERENT CLINICAL COURSE OF ISCHEMIC HEART DISEASE AFTER CORONARY ARTERY BYPASS GRAFTING SURGERY” / spz:neicon:mimmun:y:2010:i:6:p:521-528

1
Гавришева Н.А., Алексеева Г.В., Сесь Т.П., Беркович О.А., Панов А.В. Маркеры воспалительного процесса у больных с острыми и хроническими формами ишемической болезни сердца // Бюллетень научно-исследовательского института кардиологии имени В.А. Алмазова. –
(check this in PDF content)
2
04. – Т. 2, No 1. – С. 184. 2. Кетлинский С.А., Симбирцев А.С. Цитокины. – СПб.: Фолиант, 2008. – 551 c.
(check this in PDF content)
3
Левит Д.А., Лейдерман И.Н., Гусев Е.Ю., Левит А.Л. Особенности развития острофазного ответа и цитокинемии при системной воспалительной реакции инфекционного и неинфекционного генеза // Инфекции в хирургии. – 2007. – No 1. – С. 33–37.
(check this in PDF content)
4
Лысикова М., Вальд М., Масиновски З. Механизмы воспалительной реакции и воздействие на них с помощью протеолитических энзимов // Цитокины и воспаление. – 2004. – Т. 3, No 3. – С. 48-53.
(check this in PDF content)
5
Мамаев С.Н., Шульпекова Ю.О., Левина А.А., Лукина Е.Л., Ивашкин В.Г. Содержание противовоспалительных цитокинов и факторов роста в сыворотке крови больных хроническими вирусными гепатитами и циррозов печени // Рос. журн. гастроэнтерол. гепатол. колопроктол. – 2000. – Т. 10, No 5. – С. 30-34.
(check this in PDF content)
6
Моисеева О.М., Гончарова Н.С., Карелкина Е.В., Мартынова М.Г. Патологическое ремоделирование миокарда: проблемы гипертрофии, воспаления и фиброза. Клиническая и экспериментальная кардиология / Под ред. Е.В. Шляхто. – СПб., Академический медицинский центр, 2005. – С. 80-88.
(check this in PDF content)
7
Сергеенко И.В., Семенова А.Е., Масенко В.П., Хабибуллина Л.И., Габрусенко С.А., Кухарчук В.В., Беленков Ю.Н. Влияние реваскуляризации миокарда на динамику сосудистого эндотелиального и трансформирующего факторов роста у больных ишемической болезнью сердца // Кардиоваскулярная терапия и профилактика. – 2007. – Т. 6, No 5. – С. 12-17.
(check this in PDF content)
8
Фрейдлин И.С., Тотолян А.А. Клетки иммунной системы. – СПб.: Наука, 2001. – 390 с.
(check this in PDF content)
9
Bogavac-Stanojevic N., Djurovic S., JelicIvanovic Z. Circulating transforming growth factorbeta1, lipoprotein(a) and cellular adhesion molecules in angiographically assessed coronary artery disease // Clin. Chem. Lab. Med. – 2003. – Vol. 41, N 7. – P. 893-898.
(check this in PDF content)
10
Chen Y.G., Meng A.M. Negative regulation of TGF-beta signaling in development // Cell. Res. – 2004. –Vol. 14, N 6. – P. 441-449.
(check this in PDF content)
11
Dong Y., Zhang H.F., Chen H., Yang X.J., Li J., Shu C.L., Cheng Y. The cytokine secretion of peripheral blood mononucleocytes from patients infected with HCV // Immunology. – 2004. – Vol. 20, N 3. – P. 331-333.
(check this in PDF content)
12
Doran A.C., Meller N., McNamara C.A. Role of smooth muscle cells in the initiation and early progression of atherosclerosis // Arterioscler. Thromb. Vasc. Biol. – 2008. – Vol. 28, N 5. – P. 812-819.
(check this in PDF content)
13
Fernandes J.L., de Oliveira R.T., Mamoni R.L., Coelho O.R., Nicolau J.C., Blotta M.H., Serrano C.V. Jr. Pentoxifylline reduces proinflammatory and increases anti-inflammatory activity in patients with coronary artery disease: a randomized placebo-controlled study // Atherosclerosis. – 2008. – Vol. 196, N 1. – P. 434-442.
(check this in PDF content)
14
Gongora E., Sundt T.M. Myocardial Revascularization with Cardiopulmonary Bypass // Cardiac Surgery in the Adult / Ed. By L. Cohn. – New York: McGraw-Hill, 2008. – P. 599-632.
(check this in PDF content)
15
Grainger D.J. TGF-beta and atherosclerosis in man // Cardiovasc. Res. – 2007. – Vol. 74, N 2. – P. 213-222.
(check this in PDF content)
16
Gu Y.J., Mariani M.A., van Oeveren W., Grandjean J.G., Boonstra P.W. Reduction of the inflammatory response in patients undergoing minimally invasive coronary artery bypass grafting // Ann. Thorac. Surg. – 1998. – Vol. 65, N 2. – P. 420-424.
(check this in PDF content)
17
Hansson G.K. Iflammation, atherosclerosis, and coronary artery disease // N. Engl. J. Med. – 2005. – Vol. 352, N 16. – Р. 1685-1695.
(check this in PDF content)
18
Hansson G.K., Libby P. The immune response in atherosclerosis: a double-edged sword // Nat. Rev. Immunol. – 2006. – Vol. 6, N 7. – P. 508-519.
(check this in PDF content)
19
Itman C., Mendis S., Barakat B., Loveland K.L. All in the family: TGF-beta family action in testis development // Reproduction. – 2006. – Vol. 132, N 2. – P. 233-246.
(check this in PDF content)
20
Кhalil N. TGF-β: from latent to active // Microbes Infect. – 1999. – Vol. 1, N 15. – P. 12551263.
(check this in PDF content)
21
Lawrence D.А. Transforming growth factor beta: a general review // Eur. Cytokine Netw. – 1996. – Vol. 7, N 3. – P. 363-374.
(check this in PDF content)
22
Leask A. TGF beta, cardiac fibroblasts, and the fibrotic response // Cardiovasc. Res. – 2007. – Vol. 74, N 2. – P. 207-212.
(check this in PDF content)
23
Libby P., Theraux P. Pathophysiology of coronary artery disease // Circulation. – 2005. – Vol. 111, N 25. – P. 3481-3488.
(check this in PDF content)
24
Licona-Limn P., Soldevila G. The role of TGF-beta superfamily during T cell development: new insights // Immunol. Lett. – 2007. – Vol. 109, N 1. – P. 1-12.
(check this in PDF content)
25
Mallat Z., Tedgui A. The role of transforming growth factor beta in atherosclerosis: novel insights and future perspectives // Curr. Opin. Lipidol. – 2002. – Vol. 13, N 5. – P. 523-529.
(check this in PDF content)
26
Mallika V. Atherosclerosis pathophysiology and the role of novel risk factors: A clinicobiochemical perspective // Angiology. – 2007. – Vol. 58, N 5. – P. 513-522.
(check this in PDF content)
27
Matata B.M., Sosnowski A.W., Galinanes M. Off-pump bypass graft operation significantly reduces oxidative stress and inflammation // Ann. Thorac. Surg. – 2000. – Vol. 69, N 3. – P. 785-791.
(check this in PDF content)
28
Mauriello A., Sangiorgi G., Fratoni S., Palmieri G., Bonanno E., Anemona L., Schwartz R.S., Spagnoli L.G. Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction // J. Am. Coll. Cardiol. – 2005. – Vol. 45, N 10. – P. 1585-1593.
(check this in PDF content)
29
Newby A.C. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture // Physiol. Rev. – 2005. – Vol. 85, N 1. – P. 1-31.
(check this in PDF content)
30
Niccoli G., Lanza G.A., Spaziani C., Altamura L., Romagnoli E., Leone A.M., Fusco B., Trani C., Burzotta F., Mazzari M.A., Mongiardo R., Biasucci L.M., Rebuzzi A.G., Crea F. Baseline systemic inflammatory status and no-reflow phenomenon after percutaneous coronary angioplasty for acute myocardial infarction // Int. J. Cardiol. – 2007. – Vol. 117, N 3. – P. 306-311.
(check this in PDF content)
31
Padera R.F. Jr., Schoen F.J. Pathology of cardiac surgery // Cardiac Surgery in the Adult / Ed. By L. Cohn. – New York: McGraw-Hill, 2008. – Р. 111-178.
(check this in PDF content)
32
Rudijanto A. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis // Acta Med. Indones. – 2007. – Vol. 39, N 2. – P. 86-93.
(check this in PDF content)
33
Singh N.N., Ramji D.P. The role of transforming growth factor-beta in atherosclerosis // Cytokine Growth Factor Rev. – 2006. – Vol. 17, N 6. – P. 487-499.
(check this in PDF content)
34
Shen C.X., Chen H.Z., Ge J. The role of inflammatory stress in acute coronary syndrome // Chin. Med. J. – 2004. – Vol. 117, N 1. – P. 133-139.
(check this in PDF content)
35
Spagnoli L.G., Bonanno E., Sangiorgi G., Mauriello A. Role of inflammation in atherosclerosis // J. Nucl. Med. – 2007. – Vol. 48, N 11. – P. 1800-1815.
(check this in PDF content)
36
Tsuchida K., Sunada Y., Noji S., Murakami T., Uezumi A., Nakatani M. Inhibitors of the TGFbeta superfamily and their clinical applications // Mini Rev. Med. Chem. – 2006. – Vol. 6, N 11. – P. 1255-1261.
(check this in PDF content)
37
Verrecchia F., Mauviel A. Transforming growth factor-beta and fibrosis // World J. Gastroenterol. – 2007. – Vol. 13, N 22. – P. 3056-3062.
(check this in PDF content)
38
Virmani R., Burke A.P., Farb A., Kolodgie F.D. Pathology of the vulnerable plaque // J. Am. Coll. Cardiol. – 2006. – Vol. 47, N 8 – P. 13-18.
(check this in PDF content)
39
Wang X.L., Liu S.X., Wilcken D.E. Circulating transforming growth factor beta 1 and coronary artery disease // Cardiovasc Res. – 1998. – Vol. 37, N 3. – P. 829-830.
(check this in PDF content)
40
Zhang L., Yi H., Xia X.P., Zhao Y. Transforming growth factor-beta: an important role in CD4+CD25+ regulatory T cells and immune tolerance // Autoimmunity. – 2006. – Vol. 39, N 4. – P. 269-276. поступила в редакцию 30.09.2010
(check this in PDF content)